INTERNATIONAL PATENT: OYSTER POINT PHARMA, INC. FILES APPLICATION FOR "AAV VECTOR ENCODING DIAMINE OXIDASE AND USES THEREOF"

GENEVA, June 19 -- OYSTER POINT PHARMA, INC. (202 Carnegie Center, Suite 106Princeton, New Jersey 08540) filed a patent application (PCT/US2024/058985) for "AAV VECTOR ENCODING DIAMINE OXIDASE AND USES THEREOF" on Dec 06, 2024. With publication no. WO/2025/122940, the details related to the patent application was published on Jun 12, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CARLSON, Eric C. (c/o OYSTER POINT PHARMA, INC.202 Carnegie Center, Suite 106Princeton, New Jersey 08540), CHITTESTER, Dessa (c/o OYSTER POINT PHARMA, INC.202 Carnegie Center, Suite 106Princeton, New Jersey 08540)...